Inactivation of microbial infectiousness by silver nanoparticles-coated condom: A new approach to inhibit HIV- and HSV-transmitted infection

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5007-5018

  Mohammed Fayaz, A ^a   Ao, Zhujun ^a,c   Girilal, Morkattu ^b   Chen, Liyu ^c,d   Xiao, Xianzhong ^d   Kalaichelvan, P T ^b   Yao, Xiaojian ^a,c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MADRAS   (India)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Antimicrobial; Condom; HIV 1; HSV 1 2; Silver nanoparticles

Indexed keywords

POLYURETHAN; SILVER NANOPARTICLE;

ANIMAL CELL; ARTICLE; CONDOM; CONTROLLED STUDY; EMBRYO; GROWTH INHIBITION; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFRARED SPECTROSCOPY; MATERIAL COATING; MOLECULAR INTERACTION; NONHUMAN; SCANNING ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; VIRUS INACTIVATION; VIRUS INHIBITION; VIRUS TRANSMISSION; X RAY SPECTROMETRY;

ANTIVIRAL AGENTS; COATED MATERIALS, BIOCOMPATIBLE; CONDOMS; HELA CELLS; HERPES GENITALIS; HIV INFECTIONS; HUMANS; METAL NANOPARTICLES; SILVER; VIRUS INACTIVATION;

FUNGI; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIMPLEXVIRUS;

EID: 84870367218     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S34973     Document Type: Article

References (35)

1. UNAIDS. More than 80 countries increase their domestic investments for AIDS by over 50% between 2006 and 2011. July 18, 2012. Available from: http://www.unaids.org/en/resources/presscentre/pressreleaseandstatementarchive/2012/july/20120718prunaidsreport/. Accessed on August 12, 2012.
2. Pauwels R, DeClercq E. Development of vaginal microbicides for the prevention of heterosexual transmission of HIV. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;11(3):211-221.
3. Balzarini J, Van Damme L. Microbicide drug candidates to prevent HIV infection. Lancet. 2007;369(9563):787-797.
4. Turpin JA. Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opin Investig Drugs. 2002;11(8):1077-1097.
5. Kippley J, Kippley S. The Art of Natural Family Planning. 4th ed. Cincinnati, OH: The Couple to Couple League; 1996.
6. Mamo T, Moseman EA, Kolishetti N, etal. Emerging nanotechnology approaches for HIV/AIDS treatment and prevention. Nanomedicine. 2010;5(2):269-285.
7. Porcel E, Liehn S, Remita H, etal. Platinum nanoparticles: A promising material for future cancer therapy? Nanotechnology. 2010;21(8): 085103.
8. Jain KK. Nanodiagnostics: Application of nanotechnology in molecular diagnostics. Exp Rev Mol Diagn. 2003;3(2):153-161.
9. Wang J, Wang L, Sun Y, etal. Surface plasmon resonance biosensor based on Au nanoparticle in titania sol-gel membrane. Colloids Surf B Biointerfaces. 2010;75(2):520-525.
10. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: A case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004;275(1):177-182.
11. Keuk-Jun K, Woo SS, Bo K, etal. Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals. 2009; 22(2):235-242.
12. Lu L, Sun RW, Chen R, etal. Silver nanoparticles inhibit hepatitis B virus replication. Antivir Ther. 2008;13(2):253-262.
13. Sun RW, Chen R, Chung NP, Ho CM, Lin CL, Che CM. Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1infected cells. Chem Commun. 2005;28(40):5059-5061.
14. Elechiguerra JL, Burt JL, Morones JR, etal. Interaction of silver nanoparticles with HIV-1. J Nanobiotechnology. 2005;3(6):3-6.
15. Lara HH, Ayala-Nunez NV, Ixtepan-Turrent L, Rodriguez-Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. J Nanobiotechnology. 2010;8(1):1-8.
16. Jain P, Pradeep T. Potential of silver nanoparticle-coated polyurethane foam as an antibacterial water filter. Biotech. and Bioeng. 2005;90(1): 59-63.
17. Ao Z, Yu Z, Wang L, Zheng Y, Yao X. Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection. PLoS One. 2008;3(4):1995.
18. Zahariadis G, Severini A. Evaluation of a novel serology algorithm to detect herpes simplex virus 1 or 2 antibodies. Sex Transm Dis. 2010; 37(4):696-699.
19. Burleson FG, Chambers TM, Wiedbrauk DL. Plaque assay. In: Burleson FG, Chambers TM, Wiedbrauk DL, editors. Virology: A Laboratory Manual. San Diego, CA: Academic Press; 1992:74-84.
20. Kimpton J, Emerman M. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated b-galactosidase gene. J Virol. 1992;66(4):2232-2239.
21. Ao Z, Fowke KR, Cohen EA, et al. Contribution of the C-terminal tri-lysine regions of HIV-1 integrase for efficient reverse transcription and viral DNA nuclear import. Retrovirology. 2005, 2(62):1-15.
22. Fayaz AM, Balaji K, Girilal M, Ruchi Y, Kalaichelvan PT, Venkatasen R. Biogenic synthesis of silver nanoparticles and their synergistic effect with antibiotics: a study against Gram-positive and Gram-negative bacteria. Nanomedicine. 2010;6(1):103-109.
23. Guggenbichler JP, Boswald M, Lugauer S, Krall T. A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection. 1999;22(1):16-23.
24. Centers for Disease Control and Prevention. Condoms and STDs: Fact sheet for public health personnel. Atlanta, GA: Center for Disease Control and Prevention. [Updated September 13, 2011; cited November 12, 2010]. Available from: http://www.cdc.gov/condomeffectiveness/latex.htm. Accessed October 17, 2011.
25. Handley MA, Reingold AL, Shiboski S, Padian NS. Incidence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermicides. Epidemiology. 2002;13(4):431-436.
26. World Health Organization. Nonoxynol-9ineffective in preventing HIV infection. [Cited Jul 2006] Available from: http://www.who.int/mediacentre/news/notes/release55/en/index.html. Accessed July 10, 2009.
27. Bhol KC, Schechter PJ. Tropical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Br J Dermatol. 2005; 152(6):1235-1242.
28. Sibbald RG, Contreras-Ruiz J, Coutts P, Fierheller M, Rothaman A, Woo K. Bacteriology inflammation and healing a study of nanocrystalline silver dressing in chronic venous leg ulcers. Adv Skin Wound Care. 2007;20(10):549-558.
29. Baker C, Pradhan A, Pakstis L, Pochan DJ, Shah SI. Synthesis and antibacterial properties of silver nanoparticles. J Nanosci Nanotechnol. 2005;5(2):244-249.
30. Lara HH, Ixtepan-Turrent L, Garza-Trevino EN, Rodriguez-Padilla C. PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1in human cervical culture. J Nanobiotechnology. 2010;8(15):8-15.
31. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotech Adv. 2009;27(1):76-83.
32. Spira S, Wainberg MA, Loemba H, Turner D, Brenner BG. Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance. J Antimicrob Chemother. 2003;51(2):229-240.
33. Cassidy KA, Whitley RJ. New therapeutic approaches to the alpha herpes virus infections. J Antimicrob Chemother. 1997;39(2):119-128.
34. Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett PG. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses. PLoS Med. 2006;3(5):e138.
35. Weiss HA, Buvé A, Robinson NJ, etal. The epidemiology of HSV-2infection and its association with HIV infection in four urban African populations. AIDS. 2001;15:S97-S108.